Target Group, Inc. (Canada) (CBDY)
0.0010
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Target Group Debt to Equity Ratio : -1.291 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.291 |
| March 31, 2026 | -1.334 |
| December 31, 2025 | -1.413 |
| September 30, 2025 | -1.514 |
| June 30, 2025 | -1.638 |
| March 31, 2025 | -1.657 |
| December 31, 2024 | -1.687 |
| September 30, 2024 | -1.672 |
| June 30, 2024 | -1.808 |
| March 31, 2024 | -1.658 |
| December 31, 2023 | -1.831 |
| September 30, 2023 | -1.821 |
| June 30, 2023 | -1.941 |
| March 31, 2023 | -1.694 |
| December 31, 2022 | -1.795 |
| September 30, 2022 | -4.105 |
| June 30, 2022 | -4.912 |
| March 31, 2022 | -4.659 |
| December 31, 2021 | -5.710 |
| September 30, 2021 | -5.790 |
| June 30, 2021 | -2.886 |
| March 31, 2021 | -2.252 |
| December 31, 2020 | -3.307 |
| September 30, 2020 | 6.474 |
| June 30, 2020 | 0.7254 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4855 |
| December 31, 2019 | 0.0549 |
| September 30, 2019 | 0.029 |
| June 30, 2019 | 0.038 |
| March 31, 2019 | 0.1336 |
| December 31, 2018 | 0.1754 |
| September 30, 2018 | 0.31 |
| June 30, 2018 | -0.1939 |
| March 31, 2018 | -0.2638 |
| December 31, 2017 | -0.2777 |
| September 30, 2017 | -0.3114 |
| June 30, 2017 | -0.3608 |
| March 31, 2017 | -0.3209 |
| December 31, 2016 | -0.3855 |
| September 30, 2016 | -0.2568 |
| June 30, 2016 | -0.3144 |
| March 31, 2016 | -0.3311 |
| December 31, 2015 | -0.0115 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Lexaria Bioscience Corp. | 0.0183 |
| InMed Pharmaceuticals, Inc. | 0.061 |
| NervGen Pharma Corp. | 0.00 |
| Milestone Pharmaceuticals, Inc. | 7.785 |
| Clearmind Medicine, Inc. | 0.0075 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.678M |
| Total Liabilities (Quarterly) | 14.33M |
| Shareholders Equity (Quarterly) | -8.655M |
| Current Ratio | 0.1743 |
| Net Debt Paydown Yield | -7.57% |